Trial
NCT05017584
ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL)
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Duke University
Collaborators
—
Condition
Pain
Intervention
Hyperbaric bupivacaine
Why stopped
Study halted prematurely, prior to enrollment of first participant
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-27